The role of transanal total mesorectal excision (TaTME) in the surgical treatment of rectal cancer

Transanal total mesorectal excision (TaTME) is an innovative surgical approach for treating mid- and low-rectal cancers. The method offers several distinct advantages that make it superior to traditional techniques, with the principal benefits being better visualization and improved access to the lower pelvis. In this paper, we review the general assumptions of this method, with particular emphasis on the two-team (Cecil) approach. We also summarize our own experiences with the use of TaTME. Our experiences suggest that TaTME provides satisfactory oncological outcomes similar to tho­se obtained with other commonly recognized surgical techniques. Moreover, TaTME is widely accepted by patients, especially those wishing to preserve their anal sphincters. However, more multicenter studies are needed to define objective indications for TaTME and to ultimately standardize the surgical technique, as published evidence suggests that many aspects of this procedure vary substantially from center to center.